Galluzzi, Lorenzo http://orcid.org/0000-0003-2257-8500
Guilbaud, Emma http://orcid.org/0000-0001-5261-1944
Schmidt, Darby
Kroemer, Guido http://orcid.org/0000-0002-9334-4405
Marincola, Francesco M.
Article History
Accepted: 4 March 2024
First Online: 15 April 2024
Competing interests
: L.G. holds or has held research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting or advisory honoraria from Boehringer-Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. G.K. has held research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys and Vascage. G.K. is on the Board of Directors of the Bristol Myers Squibb Foundation France. D.S. is a full-time employee of Violet Therapeutics. G.K. is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. G.K. is in the scientific advisory boards of Hevolution, Institut Servier, Longevity Vision Funds and Rejuveron Life Sciences. G.K. is the inventor of patents covering therapeutic targeting of ageing, cancer, cystic fibrosis and metabolic disorders. G.K.’s wife, Laurence Zitvogel, has held research contracts with Glaxo Smyth Kline, Incyte, Lytix, Kaleido, Innovate Pharma, Daiichi Sankyo, Pilege, Merus, Transgene, 9m, Tusk and Roche, was on the Board of Directors of Transgene, is a co-founder of everImmune and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. G.K.’s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. The funders had no role in the design of the study, in the writing of the manuscript or in the decision to publish the results. F.M.M. is a full-time employee of Sonata Therapeutics.